Nardoc
ActiveSummary
Nardoc has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €214,201 and a net result of -€6,468. Equity remains stable across the filed financial years (±0.2% per year). Its solvency ranks better than 94% of 3,023 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Activity
General medical practice
NACE 86210
1 site
Size
€221,915total assets 2025
- Equity
- €214,201
- Loss
- -€6,468
Why 94raises risk1 change of registered office in 24 monthsLast filed accounts filed 59 days late; 1 of the last 3 latelowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 27.83, cash €100,357Show the evidence
Checked score
Score 2025
94
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 53% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency
100=
equity 96.5% of total assets
Liquidity
100+50
short-term debt 3.5% · cash 45.2%
Profitability
15+15
return on assets -2.9%
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.3%
12-2024: 0.3%● unchanged vs 11-2024
01-2025: 0.9%▲ +0.6 percentage points vs 12-2024
02-2025: 0.9%● unchanged vs 01-2025
03-2025: 1.0%▲ +0.1 percentage points vs 02-2025
04-2025: 0.9%▼ -0.1 percentage points vs 03-2025
05-2025: 1.0%▲ +0.1 percentage points vs 04-2025
06-2025: 1.0%● unchanged vs 05-2025
07-2025: 1.0%● unchanged vs 06-2025
08-2025: 1.0%● unchanged vs 07-2025
09-2025: 1.0%● unchanged vs 08-2025
10-2025: 1.0%● unchanged vs 09-2025
11-2025: 1.0%● unchanged vs 10-2025
12-2025: 1.0%● unchanged vs 11-2025
01-2026: 1.0%● unchanged vs 12-2025
02-2026: 1.0%● unchanged vs 01-2026
03-2026: 1.0%● unchanged vs 02-2026
04-2026: 1.1%▲ +0.1 percentage points vs 03-2026
05-2026: 1.0%▼ -0.1 percentage points vs 04-2026
06-2026: 1.0%● unchanged vs 05-2026
07-2026: 1.0%● unchanged vs 06-2026
08-2026: 1.4%▲ +0.4 percentage points vs 07-2026
09-2026: 1.8%▲ +0.4 percentage points vs 08-2026highest value
10-2026: 0.1%▼ -1.7 percentage points vs 09-2026lowest value
Credit of up to €20,000 on 30-day terms is acceptable
Liquidity ample (current ratio 27.83, compared with 16.52 in 2024, above the usual 1.5; short-term debt: 3.5% and cash: 45.2% of total assets), and 3.5% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 95% on liquidity, 4% on profitability and 32% on growth.
The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Six signals.
lowers riskraises risk
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025Net result per financial year
1819202122232425
2018 to 2025 · latest year -€6,468
raises risk · 2025 accounts filed 59 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-09-2026, 59 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filingsDeviation from the deadline
2025
59 days late
2024
31 days early
2023
30 days late
2022
3 days early
2021
31 days late
2020
30 days late
2019
29 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 21 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (4 of the last 5 filed years within 34 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
31-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · abbreviated…
- Annual accounts filedfinancial year 2024 · full…
- Weakest financial yearnet -€40,801
Financials · financial year 2025, abbreviated format
2025 annual accounts filed late (59 days) Filed on 28 September 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00526733.
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€6,468▲ 84.1%
2024 · -€40,801
Working capital
€206,984▼ 3.6%
2024 · €214,774
Trend over the years
2021 to 2025, 5 financial years 2018 to 2025, 8 financial years
The operating result stays negative: a loss of €6,129 in 2025 against €48,606 in 2024; the loss shrinks.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
Operating result-€6,129
2025
Net result-€6,468
2025
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Total assets€221,915
2025
Equity€214,201
2025
Debt€7,714
2025
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
Working capital€206,984
2025
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
Return on assets (ROA)-2.9%
2025
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Solvency96.5%
2025
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Current ratio27.83
2025
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the financial year before
favourable
unfavourable
Line20182019202020212022202320242025
Operating result€39,795-€43,156▲ 8.4%€12,164▼ 71.8%€28,073▲ 131%-€18,619-€10,626▲ 42.9%-€48,606▼ 357%-€6,129▲ 87.4%
Net result€29,506-€37,686▲ 27.7%€12,253below the sector's middle half▼ 67.5%€21,628below the sector's middle half▲ 76.5%-€14,364below the sector's middle half-€1,942below the sector's middle half▲ 86.5%-€40,801below the sector's middle half▼ 2,001%-€6,468below the sector's middle half▲ 84.1%
Equity€206,208-€243,894▲ 18.3%€256,147within the sector's middle half▲ 5.0%€277,775within the sector's middle half▲ 8.4%€263,411within the sector's middle half▼ 5.2%€261,469within the sector's middle half▼ 0.7%€220,668within the sector's middle half▼ 15.6%€214,201within the sector's middle half▼ 2.9%
Total assets€256,782-€274,369▲ 6.8%€346,494within the sector's middle half▲ 26.3%€322,776within the sector's middle half▼ 6.8%€295,023within the sector's middle half▼ 8.6%€267,819within the sector's middle half▼ 9.2%€235,179below the sector's middle half▼ 12.2%€221,915below the sector's middle half▼ 5.6%
Debt€50,574-€30,475▼ 39.7%€90,348▲ 196%€45,001▼ 50.2%€31,612▼ 29.8%€6,349▼ 79.9%€14,510▲ 129%€7,714▼ 46.8%
Working capital€196,607-€230,404▲ 17.2%€262,718above the sector's middle half▲ 14.0%€276,247above the sector's middle half▲ 5.1%€246,502within the sector's middle half▼ 10.8%€247,919within the sector's middle half▲ 0.6%€214,774within the sector's middle half▼ 13.4%€206,984within the sector's middle half▼ 3.6%
Solvency80.3%-88.9%▲ 8.6pp73.9%within the sector's middle half▼ 15.0pp86.1%above the sector's middle half▲ 12.1pp89.3%above the sector's middle half▲ 3.2pp97.6%above the sector's middle half▲ 8.3pp93.8%above the sector's middle half▼ 3.8pp96.5%above the sector's middle half▲ 2.7pp
Current ratio4.89-8.56▲ 3.675.00within the sector's middle half▼ 3.569.47above the sector's middle half▲ 4.468.95above the sector's middle half▼ 0.5240.05above the sector's middle half▲ 31.1016.52above the sector's middle half▼ 23.5227.83above the sector's middle half▲ 11.31
Return on assets (ROA)11.5%-13.7%▲ 2.2pp3.5%below the sector's middle half▼ 10.2pp6.7%below the sector's middle half▲ 3.2pp-4.9%below the sector's middle half▼ 11.6pp-0.7%below the sector's middle half▲ 4.1pp-17.3%below the sector's middle half▼ 16.6pp-2.9%below the sector's middle half▲ 14.4pp
above
within
below
the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €221,915
Fixed assets
€7,217 ▲ 9.9%
Current assets
€214,698 ▼ 6.1%
Equity and liabilities €221,915
Equity
€214,201 ▼ 2.9%
Debt
€7,714 ▼ 46.8%
Debt's share of the balance-sheet total falls from 6.2% to 3.5%. Equity and debt are lower.
Key figures and ratios
EBITDA
-€4,726▲
2024 · -€46,397
Cash flow
-€5,065▲
2024 · -€38,592
Debt to equity
0.04▼
2024 · 0.07
ROE
-3.0%▲
2024 · -18.5%
Interest coverage
-2.12▲
2024 · -17.25
Debt ≤ 1 year
€7,714▼
2024 · €13,838
Income taxes
€141▼
2024 · €148
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,908 companies that looked in July 2024 the way this one looks now, 1.1% went bankrupt within 24 months and 90.9% are still going.
- Micro
- 10 to 20 years old
- solvency 30% or more
- a small loss
1.1%
went bankrupt
7.8%
stopped otherwise
90.9%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,445 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,908 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | - | €914 | - | €600 | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €1,905 | €3,091 | €3,621 | €4,246 | €3,799 | €3,959 | €2,209 | €1,403 | ▼ 36.5% |
| Other operating charges640/8 | - | - | - | €759 | €903 | €1,201 | €1,901 | €807 | ▼ 57.5% |
| Non-recurring operating charges66A | - | - | - | - | - | - | €18,592 | - | - |
| Gross operating margin9900 | €42,154 | €47,006 | €16,049 | €33,077 | -€13,917 | -€5,466 | -€25,905 | -€3,919 | ▲ 84.9% |
| Operating profit (loss)9901 | €39,795 | €43,156 | €12,164 | €28,073 | -€18,619 | -€10,626 | -€48,606 | -€6,129 | ▲ 87.4% |
| Financial income75/76B | - | - | - | €5,099 | €7,953 | €11,009 | €10,643 | €2,029 | ▼ 80.9% |
| Recurring financial income75 | €6,144 | €6,032 | €5,682 | €5,099 | €7,953 | €11,009 | €10,643 | €2,029 | ▼ 80.9% |
| Financial charges65/66B | - | - | - | €2,133 | €3,574 | €2,202 | €2,689 | €2,226 | ▼ 17.2% |
| Recurring financial charges65 | €1,509 | €890 | €1,146 | €2,133 | €2,711 | €2,202 | €2,689 | €2,226 | ▼ 17.2% |
| Non-recurring financial charges66B | - | - | - | - | €863 | - | - | - | - |
| Profit (loss) for the period before taxes9903 | €44,429 | €48,298 | €16,701 | €31,039 | -€14,240 | -€1,819 | -€40,653 | -€6,327 | ▲ 84.4% |
| Income taxes67/77 | €14,924 | €10,612 | €4,448 | €9,411 | €124 | €123 | €148 | €141 | ▼ 4.7% |
| Profit (loss) for the period9904 | €29,506 | €37,686 | €12,253 | €21,628 | -€14,364 | -€1,942 | -€40,801 | -€6,468 | ▲ 84.1% |
| Profit (loss) for the period to be appropriated9905 | €29,506 | €37,686 | €12,253 | €21,628 | -€14,364 | -€1,942 | -€40,801 | -€6,468 | ▲ 84.1% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €256,782 | €274,369 | €346,494 | €322,776 | €295,023 | €267,819 | €235,179 | €221,915 | ▼ 5.6% |
| Fixed assets21/28 | €9,601 | €13,490 | €18,144 | €13,898 | €17,509 | €13,551 | €6,566 | €7,217 | ▲ 9.9% |
| Intangible fixed assets21 | - | - | - | €0 | - | - | - | - | - |
| Tangible fixed assets22/27 | €9,526 | €13,415 | €18,069 | €13,824 | €12,934 | €8,976 | €1,991 | €2,642 | ▲ 32.7% |
| Furniture and vehicles24 | - | - | - | €2,366 | €2,312 | €1,459 | €1,991 | €2,642 | ▲ 32.7% |
| Other tangible fixed assets26 | - | - | - | €11,457 | €10,623 | €7,516 | - | - | - |
| Financial fixed assets28 | €75 | €75 | €75 | €75 | €4,575 | €4,575 | €4,575 | €4,575 | = |
| Current assets29/58 | €247,181 | €260,879 | €328,350 | €308,877 | €277,514 | €254,268 | €228,612 | €214,698 | ▼ 6.1% |
| Amounts receivable after more than one year29 | - | - | - | €191,184 | €191,184 | €191,184 | €191,184 | €108,660 | ▼ 43.2% |
| Other amounts receivable291 | - | - | - | €191,184 | €191,184 | €191,184 | €191,184 | €108,660 | ▼ 43.2% |
| Amounts receivable within one year40/41 | €45,693 | €30,646 | €41,186 | €56,155 | €59,122 | €61,331 | €33,797 | €2,060 | ▼ 93.9% |
| Trade receivables40 | - | - | - | - | - | €12,177 | - | €1,731 | - |
| Other amounts receivable41 | - | - | - | €56,155 | €59,122 | €49,154 | €33,797 | €330 | ▼ 99.0% |
| Cash at bank and in hand54/58 | - | €32,405 | €62,465 | €50,736 | €882 | €271 | €449 | €100,357 | ▲ 224× |
| Deferred charges and accrued income490/1 | - | - | - | €10,803 | €26,326 | €1,482 | €3,182 | €3,620 | ▲ 13.8% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €256,782 | €274,369 | €346,494 | €322,776 | €295,023 | €267,819 | €235,179 | €221,915 | ▼ 5.6% |
| Equity10/15 | €206,208 | €243,894 | €256,147 | €277,775 | €263,411 | €261,469 | €220,668 | €214,201 | ▼ 2.9% |
| Contributions10/11 | €12,400 | €12,400 | - | €12,400 | €12,400 | €12,400 | €12,400 | €12,400 | = |
| Reserves13 | €193,808 | €231,494 | €243,747 | €265,375 | €251,011 | €249,069 | €208,268 | €201,801 | ▼ 3.1% |
| Non-distributable reserves130/1 | - | - | - | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Reserves not available under the articles1311 | - | - | - | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Distributable reserves133 | - | - | - | €263,515 | €249,151 | €247,209 | €206,408 | €199,941 | ▼ 3.1% |
| Amounts payable17/49 | €50,574 | €30,475 | €90,348 | €45,001 | €31,612 | €6,349 | €14,510 | €7,714 | ▼ 46.8% |
| Amounts payable after more than one year17 | - | - | €24,134 | €11,871 | - | - | - | - | - |
| Financial debts170/4 | - | - | - | €11,871 | - | - | - | - | - |
| Amounts payable within one year42/48 | €50,574 | €30,475 | €65,632 | €32,630 | €31,012 | €6,349 | €13,838 | €7,714 | ▼ 44.3% |
| Current portion of amounts payable after more than one year42 | - | - | - | €21,439 | €15,549 | - | - | - | - |
| Financial debts43 | - | - | - | €79 | - | - | - | - | - |
| Credit institutions430/8 | - | - | - | €79 | - | - | - | - | - |
| Trade debts44 | €4,033 | €530 | €35,835 | €6,611 | €10,963 | €2,316 | €8,810 | €7,073 | ▼ 19.7% |
| Suppliers440/4 | - | - | - | €6,611 | €10,963 | €2,316 | €8,810 | €7,073 | ▼ 19.7% |
| Taxes, remuneration and social security45 | - | - | - | €4,000 | €4,000 | €123 | €271 | €141 | ▼ 48.0% |
| Taxes450/3 | - | - | - | - | - | €123 | €271 | €141 | ▼ 48.0% |
| Remuneration and social security454/9 | - | - | - | €4,000 | €4,000 | - | - | - | - |
| Other amounts payable47/48 | - | - | - | €500 | €500 | €3,910 | €4,756 | €500 | ▼ 89.5% |
| Accrued charges and deferred income492/3 | - | - | - | €500 | €600 | - | €672 | - | - |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €29,506 | €37,686 | €12,253 | €21,628 | -€14,364 | -€1,942 | -€40,801 | -€6,468 | ▲ 84.1% |
| + Depreciation and write-downs630 | €1,905 | €3,091 | €3,621 | €4,246 | €3,799 | €3,959 | €2,209 | €1,403 | ▼ 36.5% |
| Operating cash flow (approximation) | €31,411 | €40,776 | €15,874 | €25,874 | -€10,565 | €2,017 | -€38,592 | -€5,065 | ▲ 86.9% |
| Investment in fixed assets (approximation) | - | -€6,980 | -€8,275 | €0 | -€7,410 | €0 | €4,775 | -€2,054 | - |
| Change in cash | - | - | €30,060 | -€11,729 | -€49,854 | -€610 | €177 | €99,908 | ▲ 563× |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Latest 10 of 13 filings with the National Bank
| Financial year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2025 | abbreviated format | 28-09-2026 | 2026-00526733 |
| 31-12-2024 | full format | 30-06-2025 | 2025-00228379 |
| 31-12-2023 | micro format | 30-08-2024 | 2024-00421214 |
| 31-12-2022 | micro format | 28-07-2023 | 2023-00285067 |
| 31-12-2021 | micro format | 31-08-2022 | 2022-20364267 |
| 31-12-2020 | micro format | 30-08-2021 | 2021-56200297 |
| 31-12-2019 | micro format | 29-08-2020 | 2020-46800048 |
| 31-12-2018 | micro format | 29-08-2019 | 2019-53600405 |
| 31-12-2017 | micro format | 29-09-2018 | 2018-66400062 |
| 31-12-2016 | micro format | 31-10-2017 | 2017-68000501 |
Similar companies · same sector, comparable size
Dr. Ewoud Deboever
BE 1008.820.388
Zonnebeke · equity €214,239
Dokter Marc Vanpoecke
BE 0798.738.283
Peer · equity €214,250
DR.COENYE EMERGENCY & SURGERY
BE 0867.643.818
Lasne · equity €214,286
Docteur Ben Hamou
BE 1007.945.806
Liège · equity €214,401
Dr Steven Buelens
BE 0832.161.416
Merchtem · equity €213,869
Of the 9,162 active companies whose main activity is general medical practice (NACE 86210), figures are known for 6,451. 5,385 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector
Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.
Directors
Directors
1 director, last change in 2024
Raphaël NARDONE
CurrentDirector (not named in the articles) · since 05-02-2024
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
1 of this company's 3 Belgian Official Gazette deeds has not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
1 person since 2024, 1 in office
- Board
| Name | Functions and periods |
|---|---|
| Raphaël NARDONE |
|
Owners and capital
Capital and shareholders
Capital over the years
- 05-02-2024 Converted to unavailable equity · €14,260
- 05-02-2024 Converted to uncalled contributions · €6,200
Group and network
Connections & network
2 connected companiesThe connected companies are in the list below.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
GéDoc
Shared director
→
Medical Corner
Shared director
→
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
28-09
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format · 59 days late
2025
30-06
NBB filing
Annual accounts filed
financial year 2024 · full format
2024
31-12
Financial
Weakest financial yearnet -€40,801
Net result drops to -€40,801, the lowest in the series; recovery starts the following year.
30-12
Gazette deed
Registered officeRegistered-office move2 facts ▸
Gazette deed
Registered office
Registered-office move2 facts ▸
- General meeting, 25-04-2025
- Registered-office move, Chaussée de Waterloo 1065 à 1180 Ucde
30-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 30 days late
05-02
Gazette deed
Appointment: Raphaël NARDONE (director)Declaration · Purpose change · Legal-form conversion10 facts ▸
Gazette deed
Appointment: Raphaël NARDONE (director)
Declaration · Purpose change · Legal-form conversion10 facts ▸
- General meeting, 25-01-2024
- Declaration, “dispense de lecture du rapport, l'assemblée dispense Monsieur le Président de donner lecture du rapport de l'administrateur” (deed in French)
- Purpose change
- Legal-form conversion, “société à responsabilité limitée (en abrégé SRL)” (deed in French)
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
- Capital conversion, “compte de capitaux propres 'apports non appelés'” (deed in French)
- Reserve release, “suppression du compte de capitaux propres statutairement indisponible, rendre ces fonds disponibles pour distribution” (deed in French)
- Amendment of the articles
- Director appointment, Raphaël NARDONE (director (not named in the articles))
- Registered office clause, “1180 Uccle, Chaussée d'Alsemberg 965” (deed in French)
2023
31-12
Financial
Liquidity more than quadruplescurrent ratio 40.05
Current ratio from 8.95 to 40.05; short-term debt falls from €31,012 to €6,349.
28-07
NBB filing
Annual accounts filed
financial year 2022 · micro format
2022
31-08
NBB filing
Annual accounts filed
financial year 2021 · micro format · 31 days late
2021
30-08
NBB filing
Annual accounts filed
financial year 2020 · micro format · 30 days late
2020
29-08
NBB filing
Annual accounts filed
financial year 2019 · micro format · 29 days late
2019
31-12
Financial
Highest result from 2018 to 2025net €37,686 ▲27.7%
Operating result €43,156, net result €37,686, both a record.
Show earlier events
29-08
NBB filing
Annual accounts filed
financial year 2018 · micro format · 29 days late
2018
29-09
NBB filing
Annual accounts filed
financial year 2017 · micro format · 60 days late
2017
31-10
NBB filing
Annual accounts filed
financial year 2016 · micro format · 92 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 13 annual accounts filed, the latest 10 are here; all 13 are under Financials.
2 of 3 deeds read
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 2 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Register details
Identification
Legal formPrivate limited company
Founded21-11-2012
Financial year end31-12
Activities, NACEBEL 2025
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0500964715
Also
9925:BE0500964715
Registered
24-08-2026
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 31 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Recognitions · licences · registrations
Legal Entity Identifier
5493003QIG136ANERS59
Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.
Sites & property
Location & real-estate footprint
Registered office, Ukkel · 1 establishment unit since 2012
Ground area
139 m²
Building footprint
138 m²
Building volume
2,175 m³
Parcel 21612C0289/00S006, Brussels · tallest building 18.6 m. Linked by address, not a title deed.
6
companies at this address
See who is registered here
1 establishment unit
NARDOC
since 2012unit no. 2.214.398.647
1 parcel
Brussels
1
(100%)
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21612C0289/00S006 | Brussels | 139 m² | 1 · 138 m² | 18.6 m · 5 |
How the parcels are linked
Good to know
The parcel matches the address exactly.
Articles of association
What the company does
- PurposeThe activities the company may carry out under its articles.
- “La société a pour objet la pratique de l'art de guérir par un ou plusieurs praticiens habilités à exercer la profession de médecin en…” (deed in French)
8 activities (deed in French)
- La société a pour objet la pratique de l'art de guérir par un ou plusieurs praticiens habilités à exercer la profession de médecin en Belgique.
- La société a pour but de leur permettre de pratiquer une médecine de qualité, dans le respect de la déontologie et de la liberté thérapeutique et diagnostique, de la dignité et de l'indépendance professionnelle, par l'amélioration et la rationalisation de leur équipement professionnel notamment :
- - en assurant la gestion d'un centre médical ou d'un cabinet médical, en ce compris l'acquisition, la location et l'entretien du matériel médical et des biens d'équipement, la facturation et la perception d'honoraires médicaux, la mise à disposition de tout ce qui est nécessaire à la pratique de l'art de guérir ;
- - en permettant la création, la construction, la location, l'acquisition, l'organisation et le fonctionnement d'un cabinet médical ou d'un centre médical de nature à faciliter l'exercice de la profession de médecin ;
- - en assurant la défense des intérêts professionnels, moraux et matériels des médecins travaillant dans le cadre de la société.
- La société se donne également pour objet de favoriser la recherche scientifique en organisant des activités de recyclage et en nouant avec tous les organismes poursuivant les mêmes buts, les relations nécessaires à la réalisation de son objet.
- D'une manière générale, la société peut exercer toute activité susceptible de favoriser la réalisation de son objet et moyennant l'accord du Conseil Provincial compétent de l'Ordre des Médecins, s'intéresser par toutes voies dans toutes entreprises ayant un but identique, analogue ou connexe ou qui est de nature à favoriser le développement de sa propre activité.
- La société pourra d'une façon générale accomplir soit seule, soit avec d'autres pour son compte ou pour le compte de tiers, toutes les opérations financières, mobilières ou immobilières se rapportant directement ou indirectement à son objet mais n'altérant pas le caractère civil de la société et sa vocation exclusivement médicale.
- Name clauseThe name the company operates under according to its articles.
- NARDOC
- Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
- “Région de Bruxelles-Capitale, sur simple décision de l’organe d’administration après en avoir informé le Conseil provincial intéressé de…” (deed in French)
Who represents it, and how
- Board ruleHow the board is made up, meets and takes decisions.
- “11, L'assemblée qui nomme le ou les administrateur(s) fixe leur nombre, la durée de leur mandat et, en cas de pluralité, leurs pouvoirs. A…” (deed in French)“12, S’il n’y a qu’un seul administrateur, la totalité des pouvoirs d’administration lui est attribuée, avec la faculté de déléguer partie de…” (deed in French)
Capital, shares and profit
- Kind of sharesWhich classes of shares exist and what rights each class carries.
- “5, 100” (deed in French)
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “9, En tout état de cause, les actions d'un actionnaire ne peuvent, à peine de nullité, être cédées entre vifs ou transmises pour cause de…” (deed in French)
- Share issue ruleHow and by whom new shares can be issued.
- “7, courrier électronique, ou, pour les personnes dont elle ne dispose pas d’une adresse électronique, par courrier ordinaire, à envoyer le…” (deed in French)
Meetings and financial year
- Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
- Third Monday of June at 18:00
Oversight and winding up
- Liquidation ruleHow assets are shared after dissolution: creditors first, then shareholders.
- One provision in the deed